Cell cycle arrest by transforming growth factor beta1 near G1/S is mediated by acute abrogation of prereplication complex activation involving an Rb-MCM interaction

Mol Cell Biol. 2010 Feb;30(3):845-56. doi: 10.1128/MCB.01152-09. Epub 2009 Nov 30.

Abstract

Understanding inhibitory mechanisms of transforming growth factor beta1 (TGF-beta1) has provided insight into cell cycle regulation and how TGF-beta1 sensitivity is lost during tumorigenesis. We show here that TGF-beta1 utilizes a previously unknown mechanism targeting the function of prereplication complexes (pre-RCs) to acutely block S-phase entry when added to cells in late G(1), after most G(1) events have occurred. TGF-beta1 treatment in early G(1) suppresses Myc and CycE-Cdk2 and blocks pre-RC assembly. However, TGF-beta1 treatment in late G(1) acutely blocks S-phase entry by inhibiting activation of fully assembled pre-RCs, with arrest occurring prior to the helicase unwinding step at G(1)/S. This acute block by TGF-beta1 requires the function of Rb in late G(1) but does not involve Myc/CycE-Cdk2 suppression or transcriptional control. Instead, Rb mediates TGF-beta1 late-G(1) arrest by targeting the MCM helicase. Rb binds the MCM complex during late G(1) via a direct interaction with Mcm7, and TGF-beta1 blocks their dissociation at G(1)/S. Loss of Rb or overexpression of Mcm7 or its Rb-binding domain alone abrogates late-G(1) arrest by TGF-beta1. These results demonstrate that TGF-beta1 acutely blocks entry into S phase by inhibiting pre-RC activation and suggest a novel role for Rb in mediating this effect of TGF-beta1 through direct interaction with and control of the MCM helicase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle Proteins / antagonists & inhibitors
  • Cell Cycle Proteins / metabolism*
  • Cell Line
  • Cyclin A / antagonists & inhibitors
  • Cyclin A / metabolism
  • Cyclin E / antagonists & inhibitors
  • Cyclin E / metabolism
  • Cyclin-Dependent Kinase 2 / antagonists & inhibitors
  • Cyclin-Dependent Kinase 2 / metabolism
  • DNA-Binding Proteins / antagonists & inhibitors
  • DNA-Binding Proteins / metabolism*
  • Dichlororibofuranosylbenzimidazole / pharmacology
  • Enzyme Inhibitors / pharmacology
  • G1 Phase / drug effects*
  • G1 Phase / physiology
  • Humans
  • Mice
  • Minichromosome Maintenance Complex Component 7
  • Nuclear Proteins / antagonists & inhibitors
  • Nuclear Proteins / metabolism*
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism
  • RNA Polymerase II / antagonists & inhibitors
  • RNA Polymerase II / metabolism
  • Retinoblastoma Protein / metabolism*
  • S Phase / drug effects*
  • S Phase / physiology
  • Transforming Growth Factor beta1 / pharmacology*

Substances

  • Cell Cycle Proteins
  • Cyclin A
  • Cyclin E
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Nuclear Proteins
  • Retinoblastoma Protein
  • Transforming Growth Factor beta1
  • Dichlororibofuranosylbenzimidazole
  • Cdc7 protein, mouse
  • Protein Serine-Threonine Kinases
  • Cdk2 protein, mouse
  • Cyclin-Dependent Kinase 2
  • RNA Polymerase II
  • Mcm7 protein, mouse
  • Minichromosome Maintenance Complex Component 7